Trial Profile
Observational clinical study of apatinib for advanced malignant solid tumors
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 31 Jul 2018 New trial record